DRG 150: EPISTAXIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS
Want to know more about Dexur's Capabilities? Get In Touch
Jan 2013 to Dec 2017   |   Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 150: EPISTAXIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | |
DRG Code |
DRG Description |
Category |
Sub Category |
DRG Group |
Surgical Category |
Case Mix Level |
Total National Projected Hospitalizations - Annualized |
Total Medicare Hospitalizations - Jan 2017 to Dec 2017 |
Total Medicare Hospitalizations - Jan 2013 to Dec 2017 |
Total Medicare Hospitalizations After Exclusion |
Avg. LOS |
GMLOS |
All Cause Readmission Rate (%) |
Unplanned Readmission Rate (%) |
Total Medicare Payments |
Payment per Day |
Payment per Discharge |
Total Medicare Charges |
Avg. Charges |
Mortality Rate (%) |
SNF Discharge Rate (%) |
Home Discharge Rate (%) |
150 |
EPISTAXIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
General Medicine |
Epistaxis |
Epistaxis |
Non Surgical |
24.69 |
NA |
1,025 |
6,098 |
5,680 |
|
|
|
|
|
|
|
|
|
|
|
|
151 |
EPISTAXIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
General Medicine |
Epistaxis |
Epistaxis |
Non Surgical |
75.31 |
NA |
2,572 |
18,605 |
17,982 |
|
|
|
|
|
|
|
|
|
|
|
|
DEMOGRAPHIC DETAILS OF DRG 150: EPISTAXIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
Race |
Total Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
White |
4,501 |
73.81 |
Black |
1,175 |
19.27 |
Hispanic |
164 |
2.69 |
|
|
|
|
|
|
|
|
|
|
|
|
Age Group ( Years ) |
Total Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
Less than 65 |
1,489 |
24.42 |
Greater than 84 |
1,277 |
20.94 |
75 to 79 |
876 |
14.37 |
|
|
|
|
|
|
|
|
|
TOP ICD DIAGNOSIS CODES FOR DRG 150: EPISTAXIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP ICD PROCEDURE CODES FOR DRG 150: EPISTAXIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP HOSPITALS ASSOCIATED WITH DRG 150: EPISTAXIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
DRG 150: EPISTAXIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | |
Category |
Sub Category |
DRG Group |
ICD Codes |
ICD Description |
National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 |
National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 |
National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 |
Total Discharges After Exclusion |
Avg. LOS |
GMLOS |
All Cause Readmission Rate (%) |
Unplanned Readmission Rate (%) |
Total Medicare Payments |
Payment per Day |
Payment per Discharge |
Total Medicare Charges |
Avg. Charges |
Mortality Rate (%) |
SNF Discharge Rate (%) |
Home Discharge Rate (%) |
General Medicine |
Epistaxis |
Epistaxis |
7847 |
Epistaxis |
NA |
3,582 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
R040 |
Epistaxis |
1,776 |
2,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
42731 |
Atrial fibrillation |
NA |
1,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
4280 |
Congestive heart failure, unspecified |
NA |
1,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
2851 |
Acute posthemorrhagic anemia |
NA |
1,503 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
2724 |
Other and unspecified hyperlipidemia |
NA |
1,295 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
4019 |
Unspecified essential hypertension |
NA |
1,139 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
D62 |
Acute posthemorrhagic anemia |
718 |
1,118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
5856 |
End stage renal disease |
NA |
1,077 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Medicine |
Epistaxis |
Epistaxis |
V5861 |
Long-term (current) use of anticoagulants |
NA |
1,056 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|